| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC0883 |
| Trial ID | ChiCTR2000036458 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPC3 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | A phase I-IIa clinical study offourth-generation chimeric antigen receptor modified autologous T cells targeting phosphatidylinositol proteoglycan-3 (GPC3) for advanced hepatocellular carcinoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Zhongshan Hospital, Fudan University |
| Cohort 1 | |||||||||
|
|||||||||